Based on research such as the c-psilocin experiment with pregnant rat mothers, which concluded that no fetuses died in the process, and our survey of almost 400 mothers, we are excited to analyze and continue finding conclusions, however, at this time, there is no conclusive evidence showing increased risk for developmental disabilities or delays or evidence suggesting that psilocybin mushrooms may be safe for use during pregnancy.
It is essential to consult with healthcare providers before making any decisions regarding psychedelic use during pregnancy.
As an organization, Mothers of the Mushroom, has been collecting data from real-world observational surveys of mothers who consumed mushrooms during pregnancy, breastfeeding and postpartum and reported their effects on their children. Read here to see what we learned from mothers who consumed psilocybin mushrooms during pregnancy.
Research indicates that psilocybin mushrooms can pass into breast milk, and there is exciting breastmilk and psilocybin research on the horizon.
We are still teasing out conclusions from our survey findings and do not have conclusive data at this time to show increased risk for developmental disabilities and delays or benefit in breastfeeding babies.
It's crucial to consider individual circumstances and consult with healthcare providers to make informed decisions about psychedelic use while breastfeeding. In our survey of almost 400 mothers, we found that 72% of mothers who consumed mushrooms continued to breastfeed as normal throughout their consumption process, observed their child’s behavior and adjusted if needed. Of the mothers who ingested mushrooms while breastfeeding, they reported increased activity in their child, in some cases more sleepiness in their children and in some other cases, less sleepiness.
See stories of psilocybin breastfeeding mothers. The dosage of psilocybin use in breastfeeding mothers ranged from microdose to high dose, with minimal interruption in feedings. The latest breakthrough in understanding psilocybin’s effect on breastmilk is being explored with breastmilk testing. Learn how to test breastmilk for psilocybin.
While research on the effects of psilocybin mushrooms on postpartum mental health is limited, studies such as the c-psilocin experiment with pregnant rat mothers provide insights into potential safety aspects. Our survey findings also suggest no correlation with increased risk for developmental disabilities or delays.
It is essential to consult with healthcare professionals for personalized advice regarding psychedelic therapy during the postpartum period.
Through our Mothers of the Mushroom research project, we have surveyed 400 mothers in their experiencing ingesting mushrooms through the birth continuum, including the postpartum period.
Here you can read more from mothers who consumed mushrooms after birth. Mothers reported a number of beneficial outcomes in their postpartum experience including alleviation of depression symptoms, less anxiety, better mood, better sleep and feeling more connected to their children. See the survey results for reported benefits.
If you have consumed psilocybin mushrooms and later discover you are pregnant, it's essential to discuss this with your healthcare provider. While research suggests potential safety based on endpoints like the c-psilocin experiment with pregnant rat mothers and our survey findings, individual circumstances may vary.
Healthcare providers can offer guidance and monitor your pregnancy closely for any potential risks.
In the Mothers of the Mushroom survey, we found no correlation between consuming psilocybin mushrooms and increased risk of miscarriage. Concerns for toxicity are valid and can be expressed with an understanding and informed prenatal care provider.
Taking a pause on consumption until you are able to connect with a care provider or MOTM educator that can answer your questions may help you make a more informed decision about how to proceed.
While research on the safety and efficacy of psilocybin mushrooms during pregnancy and postpartum is ongoing, alternative therapies and treatments such as counseling, support groups, and non-pharmacological interventions are available.
We acknowledge that psilocybin is not the fix-it pill or silver bullet to every woe in pregnancy, birth, postpartum and breastfeeding, and advocate for what we call meaningful activity to connect with and integrate into meaningful processes of promoting wellness. Some meaningful activities that pair well with psilocybin mushrooms include:
It's important to discuss treatment options with healthcare providers to determine the most suitable approach for individual needs and circumstances.
Research suggests that psilocybin mushrooms may have therapeutic potential for mental health conditions such as depression and anxiety. Additionally, anecdotal reports and emerging studies indicate that psychedelic experiences can lead to insights, emotional healing, and personal growth, which may be beneficial during the challenging transitions of pregnancy and postpartum. On our resources page, we share a number of articles and peer reviewed studies about the role of psychedelics in postpartum depression.
While research findings such as the c-psilocin experiment with pregnant rat mothers and our survey results suggest safety based on certain endpoints, it's essential to acknowledge potential risks. These may include psychological distress, challenging experiences, and unknown effects on fetal or infant development. As a grassroots action, we are working to assess through community populations the outcomes of children who were gestated with psilocybin and who consumed psilocybin breastmilk. Long-term assessment is needed to see the development of these children as they age. In the meantime, we acknowledge that consulting with healthcare providers and considering individual circumstances is crucial for making informed decisions.
While some individuals may consider using psilocybin mushrooms as a form of self-medication for mental health issues, it's important to proceed with caution. Research on safety and efficacy is still evolving, and self-medication without professional or community guidance can pose risks. Collaborating with healthcare providers and exploring alternative therapies is recommended.
If you experience a challenging or difficult psychedelic experience during pregnancy or postpartum, it's essential to seek support and assistance. This may include reaching out to a trusted friend or family member, contacting a mental health professional, or utilizing crisis support services. Integrating the experience with therapeutic support can also be beneficial for processing and healing. Our team is grateful to assist you in answering questions, seeking support and connecting you with helpful networks of care.
Due to the lack of comprehensive research on psilocybin mushrooms and pregnancy/postpartum, specific guidelines or recommendations may be limited. However, it's important to prioritize safety and informed decision-making. This includes consulting with healthcare providers, considering individual risk factors, and weighing potential benefits and risks before making any decisions about psychedelic use.
